| 1 | [SID22405172] | Active | IC50 | 1.07 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.07 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 2 | [SID22405172] | Active | IC50 | 1.07 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.07 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 3 | [SID22405172] | Active | IC50 | 1.07 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.07 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID22405172] | Active | IC50 | 1.5 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 5 | [SID22405172] | Active | IC50 | 1.5 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 6 | [SID22405172] | Active | IC50 | 1.5 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 7 | [SID22405172] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID22405172] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID22405172] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID22405172] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 11 | [SID22405172] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 12 | [SID22405172] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID22405172] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID22405172] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID22405172] | Active | Potency | 10 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 16 | [SID22405172] | Active | Potency | 10 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 17 | [SID22405172] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 18 | [SID22405172] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 19 | [SID22405172] | Active | Potency | 10 | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID22405172] | Active | Potency | 12.5893 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 21 | [SID22405172] | Active | Potency | 12.9953 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 22 | [SID22405172] | Active | Potency | 17.7828 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 23 | [SID22405172] | Active | Potency | 17.7828 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 24 | [SID22405172] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID22405172] | Active | Potency | 25.1189 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 26 | [SID22405172] | Active | Potency | 28.1838 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 27 | [SID22405172] | Active | Potency | 28.1838 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 28 | [SID99494288] | Active | IC50 | 34 | Biochemical assay for compounds that inhibit RGS4 stimulation of Galpha1 nucleotide hydrolysis under receptor-independent steady-state conditions [AID588552, Type: confirmatory] | regulator of G-protein signaling 4 [Rattus norvegicus] [gi:8394183] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99494288 | | CID | 4369759 | | Outcome | Active | | IC50 | 34 [uM] | | BioAssay | Biochemical assay for compounds that inhibit RGS4 stimulation of Galpha1 nucleotide hydrolysis under receptor-independent steady-state conditions | | AID | 588552 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Rattus norvegicus] [gi:8394183] | | PubMed | | | Data Table |  |
|
| 29 | [SID22405172] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 30 | [SID22405172] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID22405172] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID22405172] | Active | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 33 | [SID22405172] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 34 | [SID22405172] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 35 | [SID22405172] | Active | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 36 | [SID22405172] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 37 | [SID22405172] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 38 | [SID22405172] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 39 | [SID22405172] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 40 | [SID22405172] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 41 | [SID22405172] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 42 | [SID22405172] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 43 | [SID22405172] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 44 | [SID22405172] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 45 | [SID22405172] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 46 | [SID22405172] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 47 | [SID22405172] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 48 | [SID22405172] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 49 | [SID22405172] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 50 | [SID22405172] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22405172 | | CID | 4369759 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|